Edition:
United Kingdom

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

27.55USD
19 Sep 2018
Change (% chg)

-- (--)
Prev Close
$27.55
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
147,930
52-wk High
$41.75
52-wk Low
$23.01

Chart for

About

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a therapeutic approach, including the development of product candidates, for the treatment of peanut and other food allergies. The Company's therapeutic approach, which it refers to as Characterized Oral Desensitization Immunotherapy (CODIT), is... (more)

Overall

Beta: --
Market Cap(Mil.): $1,281.57
Shares Outstanding(Mil.): 50.54
Dividend: --
Yield (%): --

Financials

  AIMT.OQ Industry Sector
P/E (TTM): -- 30.93 32.76
EPS (TTM): -2.24 -- --
ROI: -50.47 15.07 14.61
ROE: -50.82 16.59 16.33

BRIEF-Aimmune Therapeutics Reports Q1 Loss Per Share $0.92

* AIMMUNE THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

08 May 2018

Competitors

  Price Chg
DBV Technologies SA (DBV.PA) €41.16 -0.02

Earnings vs. Estimates